Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp.
(CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it has come to terms for a Definitive Agreement
to acquire Artillery Holdings Ltd. (DBA Artillery Labs), (“Artillery”) a Vancouver based internet marketing company that markets
natural health products with a focus on full-body health solutions. The Company is acquiring a 100% interest of Artillery
by the issuance of 5 million shares of the Company.
Artillery has been marketing various health and wellness products since 2015. Along with its marketing
capabilities, Artillery brings a portfolio of brands that it has developed and been successful with over the past several
years. “As the Company looks to capitalize on the growing plant based nutraceutical market, it now has access to an
immediate sales platform providing revenues to support the execution of the Company’s business objectives,” said Ron Ozols,
Director of EVITRADE.
Management will continue to update the market on the activities and developments within the Company as milestones
for the Definitive Agreement are met.
Contact:
Ron Ozols, Director
EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
Email: ceo@auxellence.com or info@auxellence.com
Website: http://www.auxellence.com
CSE Micro-site: http://thecse.com/en/listings/technology/auxellence-health-corporation
About EVITRADE Health Systems Corporation (CSE: EVA, OTCQB: AXHLF)
EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to develop technologies and provide online health
solutions for improving health and chronic conditions.
Disclaimers – Forward Looking Statements
This news release may contain forward-looking statements based on assumptions and judgments of management regarding
future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or
results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or
obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its
business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings
with Canadian securities regulators which is posted on www.sedar.com, and on http://thecse.com/en/listings/technology/auxellence-health-corporation.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities
described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX
Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the
adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities
described herein in the United States. The securities described herein have not been registered under the United States
Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the
“United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the
U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
To view the original release, please click here
Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)
To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the
icons below.
Maximum News Dissemination by FSCwire. https://www.fscwire.com
Copyright © 2018 FSCwire